Ninety years of pulse oximetry: history, current status, and outlook.

CO-oximetry arterial oxygen saturation arterial oxygenation oximetry pulse oximeter pulse oximetry

Journal

Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 02 04 2024
revised: 11 07 2024
accepted: 17 07 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: ppublish

Résumé

This year, 2024, marks the 50th anniversary of the invention of pulse oximetry (PO), which was first presented by Takuo Aoyagi, an engineer from the Nihon Kohden Company, at the 13th Conference of the Japanese Society of Medical Electronics and Biological Engineering in Osaka in 1974. His discovery and the development of PO for the non-invasive measurement of peripheral arterial oxygenation represents one of the most significant chapters in the history of medical technology. It resulted from research and development efforts conducted by biochemists, engineers, physicists, physiologists, and physicians since the 1930s. The objective of this work was to provide a narrative review of the history, current status, and future prospects of PO. A comprehensive review of the literature on oximetry and PO was conducted. Our historical review examines the development of oximetry in general and PO in particular, tracing the key stages of a long and fascinating story that has unfolded from the first half of the twentieth century to the present day-an exciting journey in which serendipity has intersected with the hard work of key pioneers. This work has been made possible by the contributions of numerous key pioneers, including Kurt Kramer, Karl Matthes, Glenn Millikan, Evgenii M. Kreps, Earl H. Wood, Robert F. Show, Scott A. Wilber, William New, and, above all, Takuo Aoyagi. PO has become an integral part of modern medical care and has proven to be an important tool for physiological monitoring. The COVID-19 pandemic not only highlighted the clinical utility of PO but also revealed some of the problems with the technology. Current research in biomedical optics should address these issues to make the technology even more reliable and accurate. We discuss the necessary innovations in PO and present our thoughts on what the next generation of PO might look like.

Identifiants

pubmed: 39156662
doi: 10.1117/1.JBO.29.S3.S33307
pii: 240090SSVR
pmc: PMC11330276
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S33307

Informations de copyright

© 2024 The Authors.

Auteurs

Valentina Quaresima (V)

University of L'Aquila, Department of Life, Health and Environmental Science, L'Aquila, Italy.

Marco Ferrari (M)

University of L'Aquila, Department of Life, Health and Environmental Science, L'Aquila, Italy.

Felix Scholkmann (F)

University Hospital Zurich, University of Zurich, Biomedical Optics Research Laboratory, Department of Neonatology, Neurophotonics and Biosignal Processing Research Group, Zurich, Switzerland.
University of Bern, Institute of Complementary and Integrative Medicine, Bern, Switzerland.
University of Zurich and ETH Zurich, Neuroscience Center Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH